Sena Aksoy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sena Aksoy has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Songul Senadim
Department of Neurology, Istanbul Aydin University Faculty of Medicine, Istanbul, Türkiye
6 shared publications - Arsida Bajrami
Department of Neurology, Istanbul Aydın University Florya Medical Park Hospital, Istanbul 34295, Turkey
5 shared publications - Serdar Geyik
Department of Radiology, Istanbul Aydin University Faculty of Medicine, Istanbul, Türkiye
4 shared publications - Serdar Geyik
Istanbul Aydın University Florya Medicalpark Hospital Stroke Center, Neuroradiology, Istanbul, Turkey
2 shared publications Ali Burak Kızılırmak
Research Center for Translational Medicine, Koç University
1 shared publication- Ali Burak Kızılırmak
Research Center for Translational Medicine, Koç University, Istanbul 34010, Turkey
1 shared publication
Latest Publications
- 9 June 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 269, 109538
Endovascular treatment of acute common carotid artery occlusion: Mechanisms, therapeutic challenges, and clinical outcomes
- 9 June 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 269, 109538
Endovascular treatment of acute common carotid artery occlusion: Mechanisms, therapeutic challenges, and clinical outcomes
- Open Access
- 14 May 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (5) , 526
Mechanical Thrombectomy in Patients with Malignancy: Comparable Procedural Success but Less Favorable Long-Term Outcomes
Background and Aims: Patients with malignancy are frequently excluded from randomized thrombectomy trials, and evidence regarding the safety and efficacy of mechanical thrombectomy (MT) in this population remains incompletely defined. We aimed to compare procedural success, functional outcomes, and mortality between acute ischemic stroke (AIS) patients with and without malignancy undergoing MT. Methods: We retrospectively analyzed 110 patients treated with MT. Patients were stratified into two groups: those with malignancy (n = 48) and those without malignancy (n = 62). Baseline demographics, vascular risk factors, procedural metrics, angiographic outcomes, and clinical outcomes including functional independence (modified Rankin Scale [mRS] 0–2), 90-day mortality and intracranial hemorrhage were compared. Results: Baseline demographics and admission stroke severity were similar between groups. Smoking was significantly more frequent in the malignancy group (25% vs. 11.3%, p < 0.001). Successful reperfusion (TICI 2b-3) was achieved in 95.8% of malignancy patients and 98.4% of controls (p = 0.51). Functional independence at 90 days was lower in the malignancy group (42.6% vs. 61.3%, p = 0.04), whereas 90-day mortality was significantly higher (44.7% vs. 19.4%, p = 0.004); this increase in mortality remained significant after multivariate analysis. There were no significant differences in rates of intracranial hemorrhage between groups (p = 0.53). Conclusions: Mechanical thrombectomy is technically effective and safe in patients with malignancy; however, long-term functional recovery and survival are significantly worse, likely reflecting the effect of cancer itself rather than procedural factors. Careful patient selection and multidisciplinary decision-making are essential in this population.
- 14 May 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (5) , 526
Open AccessMechanical Thrombectomy in Patients with Malignancy: Comparable Procedural Success but Less Favorable Long-Term Outcomes
Background and Aims: Patients with malignancy are frequently excluded from randomized thrombectomy trials, and evidence regarding the safety and efficacy of mechanical thrombectomy (MT) in this population remains incompletely defined. We aimed to compare procedural success, functional outcomes, and mortality between acute ischemic stroke (AIS) patients with and without malignancy undergoing MT. Methods: We retrospectively analyzed 110 patients treated with MT. Patients were stratified into two groups: those with malignancy (n = 48) and those without malignancy (n = 62). Baseline demographics, vascular risk factors, procedural metrics, angiographic outcomes, and clinical outcomes including functional independence (modified Rankin Scale [mRS] 0–2), 90-day mortality and intracranial hemorrhage were compared. Results: Baseline demographics and admission stroke severity were similar between groups. Smoking was significantly more frequent in the malignancy group (25% vs. 11.3%, p < 0.001). Successful reperfusion (TICI 2b-3) was achieved in 95.8% of malignancy patients and 98.4% of controls (p = 0.51). Functional independence at 90 days was lower in the malignancy group (42.6% vs. 61.3%, p = 0.04), whereas 90-day mortality was significantly higher (44.7% vs. 19.4%, p = 0.004); this increase in mortality remained significant after multivariate analysis. There were no significant differences in rates of intracranial hemorrhage between groups (p = 0.53). Conclusions: Mechanical thrombectomy is technically effective and safe in patients with malignancy; however, long-term functional recovery and survival are significantly worse, likely reflecting the effect of cancer itself rather than procedural factors. Careful patient selection and multidisciplinary decision-making are essential in this population.
- Open Access
- 3 May 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (9) , 1390
Histopathological Analysis of Thrombi in Acute Ischemic Stroke: An Exploratory Study of Thrombus Composition and CD34-Positive Endothelial Cells
Background/Objectives: Mechanical thrombectomy (MT) enables direct examination of the retrieved thrombus in acute ischemic stroke. Thrombus composition may influence treatment outcomes and reflect underlying stroke mechanisms. This study aimed to analyze thrombus histological composition and CD34-positive endothelial cells and evaluate their association with clinical and radiological characteristics. Methods: Fifty-six patients with acute ischemic stroke who underwent MT were included. Thrombi were classified as fibrin-dominant or red blood cell (RBC)-dominant using hematoxylin–eosin staining (H&E). Endothelial cells were identified via CD34 immunostaining. Associations between thrombus composition, procedural variables, imaging findings, and clinical outcomes were analyzed. Results: Forty-one (73.2%) thrombi were fibrin-dominant, and 15 (26.8%) were RBC-dominant. Fibrin-dominant thrombi were significantly associated with more distal occlusions (p = 0.027) and with the use of stent-retrievers (p = 0.045). RBC-dominant thrombi were more frequently associated with the hyperdense artery sign (HAS) (p = 0.015). CD34-positive staining correlated with shorter symptom-to-door (p = 0.017) and symptom-to-puncture times (p < 0.001). Endothelial ingrowth was more common in thrombi from proximal occlusions (p = 0.017). No significant associations were observed between thrombus composition and recanalization success, number of passes, or functional outcomes. The association between RBC-dominant thrombi and HAS supports the potential role of imaging markers in predicting thrombus composition prior to intervention. In addition, the presence and distribution of CD34-positive endothelial cells in relation to time intervals and occlusion location may reflect dynamic processes such as thrombus organization and vessel wall interaction. Conclusions: These findings highlight the heterogeneous nature of thrombus in acute ischemic stroke. Further studies are needed to clarify the biological and clinical implications of these observations.
- 3 May 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (9) , 1390
Open AccessHistopathological Analysis of Thrombi in Acute Ischemic Stroke: An Exploratory Study of Thrombus Composition and CD34-Positive Endothelial Cells
Background/Objectives: Mechanical thrombectomy (MT) enables direct examination of the retrieved thrombus in acute ischemic stroke. Thrombus composition may influence treatment outcomes and reflect underlying stroke mechanisms. This study aimed to analyze thrombus histological composition and CD34-positive endothelial cells and evaluate their association with clinical and radiological characteristics. Methods: Fifty-six patients with acute ischemic stroke who underwent MT were included. Thrombi were classified as fibrin-dominant or red blood cell (RBC)-dominant using hematoxylin–eosin staining (H&E). Endothelial cells were identified via CD34 immunostaining. Associations between thrombus composition, procedural variables, imaging findings, and clinical outcomes were analyzed. Results: Forty-one (73.2%) thrombi were fibrin-dominant, and 15 (26.8%) were RBC-dominant. Fibrin-dominant thrombi were significantly associated with more distal occlusions (p = 0.027) and with the use of stent-retrievers (p = 0.045). RBC-dominant thrombi were more frequently associated with the hyperdense artery sign (HAS) (p = 0.015). CD34-positive staining correlated with shorter symptom-to-door (p = 0.017) and symptom-to-puncture times (p < 0.001). Endothelial ingrowth was more common in thrombi from proximal occlusions (p = 0.017). No significant associations were observed between thrombus composition and recanalization success, number of passes, or functional outcomes. The association between RBC-dominant thrombi and HAS supports the potential role of imaging markers in predicting thrombus composition prior to intervention. In addition, the presence and distribution of CD34-positive endothelial cells in relation to time intervals and occlusion location may reflect dynamic processes such as thrombus organization and vessel wall interaction. Conclusions: These findings highlight the heterogeneous nature of thrombus in acute ischemic stroke. Further studies are needed to clarify the biological and clinical implications of these observations.
- Open Access
- 25 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (9) , 1288
Angiographic Success Does Not Fully Reflect Tissue-Level Reperfusion: New Diffusion-Weighted Imaging Lesions After True Complete (TICI 3) Recanalization
Background and Purpose: Complete angiographic reperfusion (TICI 3) is considered the optimal procedural endpoint of mechanical thrombectomy (MT) in acute ischemic stroke. However, new diffusion-weighted imaging (DWI) lesions are frequently observed despite apparent angiographic success. We aimed to investigate the incidence, morphological patterns, and clinical relevance of these lesions in a strictly defined TICI 3 cohort. Methods: In this retrospective single-center study, 89 patients with anterior circulation large-vessel occlusion (LVO) who achieved true TICI 3 were analyzed. Baseline and follow-up Magnetic Resonance Imaging (MRI) within 48 h were systematically compared using paired diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps to identify new lesions. Lesions were classified according to morphology and distribution. Stroke etiology was assessed using TOAST criteria. Functional outcomes were evaluated using the 90-day modified Rankin Scale (mRS) with the Rankin Focused Assessment. Results: New DWI lesions were detected in 28 of 89 patients (31.5%). The predominant pattern was millimetric cortical foci (85.7%), most frequently ipsilateral to the recanalized vessel (78.6%), with fewer contralateral (14.3%) and bilateral (7.1%) lesions. Territorial infarcts and isolated basal ganglia infarcts were each identified in 14.3% of patients, with some overlap between categories. No significant differences were observed between patients with and without new lesions regarding baseline characteristics or procedural metrics (all p > 0.05). Importantly, the presence of new DWI lesions was not associated with 90-day functional outcome (p = 0.930) or survival (p = 0.613). Conclusions: New DWI lesions are common even after complete angiographic reperfusion, highlighting a persistent dissociation between macrovascular success and tissue-level integrity. Although predominantly small and clinically silent in the short term, these findings underscore the limitations of angiographic endpoints alone and support the need for strategies targeting microvascular protection and prevention of distal embolization.
- 25 April 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (9) , 1288
Open AccessAngiographic Success Does Not Fully Reflect Tissue-Level Reperfusion: New Diffusion-Weighted Imaging Lesions After True Complete (TICI 3) Recanalization
Background and Purpose: Complete angiographic reperfusion (TICI 3) is considered the optimal procedural endpoint of mechanical thrombectomy (MT) in acute ischemic stroke. However, new diffusion-weighted imaging (DWI) lesions are frequently observed despite apparent angiographic success. We aimed to investigate the incidence, morphological patterns, and clinical relevance of these lesions in a strictly defined TICI 3 cohort. Methods: In this retrospective single-center study, 89 patients with anterior circulation large-vessel occlusion (LVO) who achieved true TICI 3 were analyzed. Baseline and follow-up Magnetic Resonance Imaging (MRI) within 48 h were systematically compared using paired diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps to identify new lesions. Lesions were classified according to morphology and distribution. Stroke etiology was assessed using TOAST criteria. Functional outcomes were evaluated using the 90-day modified Rankin Scale (mRS) with the Rankin Focused Assessment. Results: New DWI lesions were detected in 28 of 89 patients (31.5%). The predominant pattern was millimetric cortical foci (85.7%), most frequently ipsilateral to the recanalized vessel (78.6%), with fewer contralateral (14.3%) and bilateral (7.1%) lesions. Territorial infarcts and isolated basal ganglia infarcts were each identified in 14.3% of patients, with some overlap between categories. No significant differences were observed between patients with and without new lesions regarding baseline characteristics or procedural metrics (all p > 0.05). Importantly, the presence of new DWI lesions was not associated with 90-day functional outcome (p = 0.930) or survival (p = 0.613). Conclusions: New DWI lesions are common even after complete angiographic reperfusion, highlighting a persistent dissociation between macrovascular success and tissue-level integrity. Although predominantly small and clinically silent in the short term, these findings underscore the limitations of angiographic endpoints alone and support the need for strategies targeting microvascular protection and prevention of distal embolization.
- Open Access
- 19 March 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1723099
Hyperintense acute reperfusion marker (HARM) and thrombus analysis in acute ischemic stroke
Mechanical thrombectomy allows thrombus analysis in acute ischemic stroke. The extravasation of contrast material into the cerebrospinal fluid (CSF) on fluid-attenuated inversion recovery (FLAIR) imaging is referred to as a hyperintense acute reperfusion marker (HARM), which indicates deterioration of the blood–brain barrier (BBB). In this study, we aimed to examine the relationship between the histopathological features of thrombi and HARM in acute ischemic stroke. A total of 56 patients who underwent mechanical thrombectomy (MT) were included in the study. Procedural data, including the number of passes, techniques used, and recanalization scores based on the modified Thrombolysis in Cerebral Infarction (mTICI) scale, were documented. FLAIR imaging was performed 24 h after contrast administration. The presence of contrast extravasation into the cerebral sulci was defined as a positive HARM. A total of 52 thrombi were successfully retrieved and analyzed. Thrombus sections were stained with hematoxylin and eosin (H&E) to evaluate their fibrin and erythrocyte composition. Immunohistochemical staining using CD3, CD20, and CD45 antibodies was performed to identify T lymphocytes, B lymphocytes, and total leukocytes, respectively. In our study, it was found that clinical outcomes—measured by National Institutes of Health Stroke Scale (NIHSS) scores at 24 h and modified Rankin Scale (mRS) scores at 90 days—were significantly worse in HARM-positive patients. A histopathological analysis revealed that thrombi from HARM-positive patients were predominantly rich in fibrin, suggesting a potential association between thrombus composition and BBB disruption. Future studies incorporating more detailed thrombus characterization alongside advanced radiological markers may yield valuable insights into stroke pathophysiology.
- 19 March 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1723099
Open AccessHyperintense acute reperfusion marker (HARM) and thrombus analysis in acute ischemic stroke
Mechanical thrombectomy allows thrombus analysis in acute ischemic stroke. The extravasation of contrast material into the cerebrospinal fluid (CSF) on fluid-attenuated inversion recovery (FLAIR) imaging is referred to as a hyperintense acute reperfusion marker (HARM), which indicates deterioration of the blood–brain barrier (BBB). In this study, we aimed to examine the relationship between the histopathological features of thrombi and HARM in acute ischemic stroke. A total of 56 patients who underwent mechanical thrombectomy (MT) were included in the study. Procedural data, including the number of passes, techniques used, and recanalization scores based on the modified Thrombolysis in Cerebral Infarction (mTICI) scale, were documented. FLAIR imaging was performed 24 h after contrast administration. The presence of contrast extravasation into the cerebral sulci was defined as a positive HARM. A total of 52 thrombi were successfully retrieved and analyzed. Thrombus sections were stained with hematoxylin and eosin (H&E) to evaluate their fibrin and erythrocyte composition. Immunohistochemical staining using CD3, CD20, and CD45 antibodies was performed to identify T lymphocytes, B lymphocytes, and total leukocytes, respectively. In our study, it was found that clinical outcomes—measured by National Institutes of Health Stroke Scale (NIHSS) scores at 24 h and modified Rankin Scale (mRS) scores at 90 days—were significantly worse in HARM-positive patients. A histopathological analysis revealed that thrombi from HARM-positive patients were predominantly rich in fibrin, suggesting a potential association between thrombus composition and BBB disruption. Future studies incorporating more detailed thrombus characterization alongside advanced radiological markers may yield valuable insights into stroke pathophysiology.
- Open Access
- 20 February 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (3) , 276
Correction to: Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report
- 20 February 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (3) , 276
Open AccessCorrection to: Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report
- 15 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 164
Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report
- 15 January 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (1) , 164
Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report